Literature DB >> 2559846

Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.

C E Nord1, A Lindmark, I Persson.   

Abstract

The activity of the new streptogramin RP 59500 in vitro was determined against 380 strains of anaerobic bacteria by an agar dilution method and compared with that of pyostacine, piperacillin, cefoxitin, imipenem, clindamycin, metronidazole and chloramphenicol. RP 59500 and imipenem were the most active agents tested. On the basis of these results, RP 59500 appears to be a promising antimicrobial agent for treatment of anaerobic infections, further clinical investigations being warranted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559846     DOI: 10.1007/BF01975171

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  2 in total

1.  Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.

Authors:  K Dornbusch; C E Nord; B Olsson-Liljeqvist
Journal:  Scand J Infect Dis Suppl       Date:  1979

2.  Structure activity relationships in lincosamide and streptogramin antibiotics.

Authors:  F Le Goffic
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

  2 in total
  5 in total

Review 1.  Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Authors:  H M Lamb; D P Figgitt; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Platforms for antibiotic discovery.

Authors:  Kim Lewis
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

Review 3.  Quinupristin-dalfopristin.

Authors:  H M Bryson; C M Spencer
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

Review 4.  Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use.

Authors:  R G Finch
Journal:  Drugs       Date:  1996       Impact factor: 9.546

5.  Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Authors:  C Betriu; M Gómez; M L Palau; A Sánchez; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.